Product Description:

Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:

  •  an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
  • fulvestrant in women with disease progression following endocrine therapy.

Product Features:

Product Name : Palbonix
Generic Name : Palbociclib
Formulation : Capsule
Available Pack Size : 21’s Pot
Available Strength : 125mg
Registrations : Export Only